Information Provided By:
Fly News Breaks for February 27, 2019
WMGI
Feb 27, 2019 | 08:55 EDT
Jefferies analyst Raj Denhoy raised his price target for Wright Medical Group to $40 following the company's Q4 results. Wright is "hitting its stride" with 10% organic growth in Q4 driven by good results in upper extremities and biologics, Denhoy tells investors in a post-earnings research note. He keeps a Buy rating on the shares.
News For WMGI From the Last 2 Days
There are no results for your query WMGI